US Stock MarketDetailed Quotes

AnaptysBio (ANAB)

Watchlist
  • 58.880
  • +7.610+14.84%
Close Apr 24 16:00 ET
  • 59.850
  • +0.970+1.65%
Post 20:01 ET
1.69BMarket Cap-128.00P/E (TTM)

AnaptysBio (ANAB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
157.01%234.6M
151.08%108.25M
154.26%76.32M
102.93%22.26M
286.84%27.77M
432.03%91.28M
378.77%43.11M
804.67%30.02M
217.08%10.97M
422.49%7.18M
Operating revenue
157.01%234.6M
151.08%108.25M
154.26%76.32M
102.93%22.26M
286.84%27.77M
432.03%91.28M
378.77%43.11M
804.67%30.02M
217.08%10.97M
422.49%7.18M
Cost of revenue
Gross profit
Operating expense
-9.47%186.71M
-21.66%41.35M
-21.14%41.62M
-5.57%48.43M
12.01%55.31M
18.37%206.23M
20.51%52.78M
28.56%52.77M
17.63%51.29M
7.88%49.38M
Selling and administrative expenses
19.69%50.74M
54.89%15.79M
-3.34%10.21M
14.14%10.61M
14.52%14.13M
1.06%42.39M
-0.80%10.19M
3.83%10.56M
-12.97%9.3M
14.05%12.34M
-General and administrative expense
19.69%50.74M
54.89%15.79M
-3.34%10.21M
14.14%10.61M
14.52%14.13M
1.06%42.39M
-0.80%10.19M
3.83%10.56M
-12.97%9.3M
14.05%12.34M
Research and development costs
-17.01%135.97M
-39.99%25.56M
-25.60%31.41M
-9.94%37.82M
11.17%41.18M
23.86%163.84M
27.04%42.59M
36.71%42.21M
27.56%42M
5.96%37.04M
Operating profit
141.67%47.9M
791.84%66.9M
252.50%34.7M
35.10%-26.17M
34.74%-27.54M
26.82%-114.95M
72.21%-9.67M
39.69%-22.76M
-0.44%-40.32M
4.95%-42.2M
Net non-operating interest income expense
-119.17%-66.39M
-41.69%-17.2M
-94.18%-19.59M
-152.01%-15.95M
-687.54%-13.65M
-3,934.56%-30.29M
-15,465.38%-12.14M
-2,485.11%-10.09M
-2,245.76%-6.33M
-1,255.33%-1.73M
Non-operating interest income
-31.80%13.5M
-52.35%2.51M
-45.08%2.92M
-20.96%3.65M
-3.73%4.41M
4.88%19.79M
7.85%5.26M
9.68%5.32M
-0.64%4.62M
2.18%4.58M
Non-operating interest expense
59.51%79.89M
13.26%19.71M
46.08%22.52M
79.00%19.61M
185.91%18.06M
176.98%50.09M
251.03%17.4M
247.84%15.41M
151.33%10.95M
45.69%6.32M
Other net income (expense)
38,685.71%5.43M
-114.29%-3K
3.53M
95,200.00%1.9M
100.19%14K
21K
-600.00%-5K
50.00%-2K
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
-Less:Restructuring and merger&acquisition
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
38,685.71%5.43M
-114.29%-3K
----
--3.53M
95,200.00%1.9M
800.00%14K
--21K
-600.00%-5K
----
50.00%-2K
Income before tax
91.00%-13.07M
328.06%49.7M
146.00%15.11M
17.28%-38.59M
10.59%-39.29M
11.24%-145.23M
48.38%-21.79M
11.95%-32.85M
-17.08%-46.65M
0.72%-43.94M
Income tax
5,366.67%164K
1,450.00%81K
0
333.33%39K
44K
175.00%3K
-50.00%-6K
0
9K
0
Net income
90.89%-13.23M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
11.24%-145.23M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
Net income continuous Operations
90.89%-13.23M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
11.24%-145.23M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
Minority interest income
Net income attributable to the parent company
90.89%-13.23M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
11.24%-145.23M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
90.89%-13.23M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
11.24%-145.23M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
Basic earnings per share
91.02%-0.46
348.61%1.79
147.37%0.54
21.64%-1.34
21.95%-1.28
15.79%-5.12
54.72%-0.72
19.15%-1.14
-14.00%-1.71
-3.80%-1.64
Diluted earnings per share
91.02%-0.46
319.44%1.58
145.61%0.52
21.64%-1.34
21.95%-1.28
15.79%-5.12
54.72%-0.72
19.15%-1.14
-14.00%-1.71
-3.80%-1.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 157.01%234.6M151.08%108.25M154.26%76.32M102.93%22.26M286.84%27.77M432.03%91.28M378.77%43.11M804.67%30.02M217.08%10.97M422.49%7.18M
Operating revenue 157.01%234.6M151.08%108.25M154.26%76.32M102.93%22.26M286.84%27.77M432.03%91.28M378.77%43.11M804.67%30.02M217.08%10.97M422.49%7.18M
Cost of revenue
Gross profit
Operating expense -9.47%186.71M-21.66%41.35M-21.14%41.62M-5.57%48.43M12.01%55.31M18.37%206.23M20.51%52.78M28.56%52.77M17.63%51.29M7.88%49.38M
Selling and administrative expenses 19.69%50.74M54.89%15.79M-3.34%10.21M14.14%10.61M14.52%14.13M1.06%42.39M-0.80%10.19M3.83%10.56M-12.97%9.3M14.05%12.34M
-General and administrative expense 19.69%50.74M54.89%15.79M-3.34%10.21M14.14%10.61M14.52%14.13M1.06%42.39M-0.80%10.19M3.83%10.56M-12.97%9.3M14.05%12.34M
Research and development costs -17.01%135.97M-39.99%25.56M-25.60%31.41M-9.94%37.82M11.17%41.18M23.86%163.84M27.04%42.59M36.71%42.21M27.56%42M5.96%37.04M
Operating profit 141.67%47.9M791.84%66.9M252.50%34.7M35.10%-26.17M34.74%-27.54M26.82%-114.95M72.21%-9.67M39.69%-22.76M-0.44%-40.32M4.95%-42.2M
Net non-operating interest income expense -119.17%-66.39M-41.69%-17.2M-94.18%-19.59M-152.01%-15.95M-687.54%-13.65M-3,934.56%-30.29M-15,465.38%-12.14M-2,485.11%-10.09M-2,245.76%-6.33M-1,255.33%-1.73M
Non-operating interest income -31.80%13.5M-52.35%2.51M-45.08%2.92M-20.96%3.65M-3.73%4.41M4.88%19.79M7.85%5.26M9.68%5.32M-0.64%4.62M2.18%4.58M
Non-operating interest expense 59.51%79.89M13.26%19.71M46.08%22.52M79.00%19.61M185.91%18.06M176.98%50.09M251.03%17.4M247.84%15.41M151.33%10.95M45.69%6.32M
Other net income (expense) 38,685.71%5.43M-114.29%-3K3.53M95,200.00%1.9M100.19%14K21K-600.00%-5K50.00%-2K
Special income (charges) --0------------------0----------------
-Less:Restructuring and merger&acquisition --0------------------0----------------
Other non- operating income (expenses) 38,685.71%5.43M-114.29%-3K------3.53M95,200.00%1.9M800.00%14K--21K-600.00%-5K----50.00%-2K
Income before tax 91.00%-13.07M328.06%49.7M146.00%15.11M17.28%-38.59M10.59%-39.29M11.24%-145.23M48.38%-21.79M11.95%-32.85M-17.08%-46.65M0.72%-43.94M
Income tax 5,366.67%164K1,450.00%81K0333.33%39K44K175.00%3K-50.00%-6K09K0
Net income 90.89%-13.23M327.75%49.61M146.00%15.11M17.21%-38.63M10.49%-39.33M11.24%-145.23M48.39%-21.78M11.95%-32.85M-17.10%-46.66M0.72%-43.94M
Net income continuous Operations 90.89%-13.23M327.75%49.61M146.00%15.11M17.21%-38.63M10.49%-39.33M11.24%-145.23M48.39%-21.78M11.95%-32.85M-17.10%-46.66M0.72%-43.94M
Minority interest income
Net income attributable to the parent company 90.89%-13.23M327.75%49.61M146.00%15.11M17.21%-38.63M10.49%-39.33M11.24%-145.23M48.39%-21.78M11.95%-32.85M-17.10%-46.66M0.72%-43.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 90.89%-13.23M327.75%49.61M146.00%15.11M17.21%-38.63M10.49%-39.33M11.24%-145.23M48.39%-21.78M11.95%-32.85M-17.10%-46.66M0.72%-43.94M
Basic earnings per share 91.02%-0.46348.61%1.79147.37%0.5421.64%-1.3421.95%-1.2815.79%-5.1254.72%-0.7219.15%-1.14-14.00%-1.71-3.80%-1.64
Diluted earnings per share 91.02%-0.46319.44%1.58145.61%0.5221.64%-1.3421.95%-1.2815.79%-5.1254.72%-0.7219.15%-1.14-14.00%-1.71-3.80%-1.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More